Medi Whale Co. introduced their research in EuroPCR, the biggest cardiology workshop in Paris. This annually holding workshop is mainly focused on invasive cardiac surgery. In this year, 10,987 professionals were participated and shared their individual field research. From this workshop, Medi-Whale represented the research result of AI which can assist physician’s diagnosis and evaluation
Before when deep learning was not displayed in ophthalmology, diabetic retinopathy was needed to be evaluated and prescribed through human effort. IDx-DR is using the algorithm which applied two development operating set (high specificity & high sensitivity) to identify diabetic retinopathy and to evaluate patient’s common status. Referable and non-referable diabetic retinopathies were evaluated by
01:54:25The most common trend in medical AI society is using deep learning technology which can analyze medical image data. Deep learning is the process of training neural network which allows an algorithm to program itself by learning from a large set of models that perform the desired behavior. It is an important source in our
The 2nd Technology Investment Partnering (Tech-investment Road Show) took place at Avison Bio Medical Research Center (ABMRC) in 30th, April. It was hosted by the Ministry of Health and Welfare and was conducted by Korea Health Industry Development Institute. This ‘visiting investment fair’ visits occupied companies in bio-health field and host a partnering with the
Medi Whale Co. introduced their first product, ‘Dr. Noon’ at the 34th Korea International Medical&Hospital Equipment Show (KIMES 2018) opened from last 15th March. KIMES 2018 was held at COEX from March 15th to 18th for four days. KIMES, started from 1980, is the biggest medical and hospital equipment exhibition in Korea, which have led
Khanty-Mansiysk district and Medi Whale signed an agreement for demonstration of ‘AI eye doctor’ of Medi Whale. Medi Whale is an AI healthcare start-up developing an eye examination software using artificial intelligence. Its AI shows accuracy over 95% screening eye diseases, proving their technical expertise. Both parties agreed that this ‘AI eye doctor’ showing a
Recent Posts
-
Medi Whale is proceeding a prospective clinical trial in India
Medi Whale Inc. announced on the last 18th that... -
Medi Whale got a tech transfer from Yonsei Medical Center
Medi Whale Inc. got a tech transfer from Yonsei... -
Medi Whale partnered with Siloam Eye Hospital
On the last 17th, Medi Whale Inc. and Siloam Ey... -
Medi Whale Inc. opens an all-in-one eye disease auto-diagnostic device at Asian Pacific Vitreo-Retina Society 2018
On last 14th of December, Medi Whale Inc. opene... -
Medi Whale Inc. established a sales headquarter in Singapore
Medi Whale Inc. announced on last 4th December ...
